Hypoglycemia, its implications in clinical practice, and possible ways to prevent it

被引：5

作者：

Maffioli, Pamela ^{[1
,2
]}

Derosa, Giuseppe ^{[1
,2
,3
]}

机构：

[1] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy

[2] Fdn IRCCS Policlin S Matteo, Pavia, Italy

[3] Univ Pavia, Ctr Study Endocrine Metab Pathophysiol & Clin Res, I-27100 Pavia, Italy

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2014年 / 30卷 / 05期

关键词：

DPP-4; inhibitors; Hypoglycemia; Sulfonylureas Type 2 diabetes mellitus; TYPE-2; DIABETES-MELLITUS; ADD-ON THERAPY; CARDIAC REPOLARIZATION; METFORMIN; SAXAGLIPTIN; GLIPIZIDE; GLIBENCLAMIDE; PIOGLITAZONE; ASSOCIATION; MECHANISMS;

D O I：

10.1185/03007995.2014.890096

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：771 / 773

页数：3

共 28 条

[1] Mechanisms of the glycaemic effects of sulfonylureas [J].

Ashcroft, FM .

HORMONE AND METABOLIC RESEARCH, 1996, 28 (09) :456-463

[2] Characteristics and outcomes of older patients presenting to the emergency department after a fall: a retrospective analysis [J].

Bell, AJ ;

Talbot-Stern, JK ;

Hennessy, A .

MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (04) :179-182

[3] Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs [J].

Bron, Morgan ;

Marynchenko, Maryna ;

Yang, Hongbo ;

Yu, Andrew P. ;

Wu, Eric Q. .

POSTGRADUATE MEDICINE, 2012, 124 (01) :124-132

[4] A comparison between sitagliptin or glibenclamide in addition to metformin plus pioglitazone on glycaemic control and -cell function: the triple oral therapy [J].

Derosa, G. ;

Cicero, A. F. G. ;

Franzetti, I. G. ;

Querci, F. ;

Carbone, A. ;

Piccinni, M. N. ;

D'Angelo, A. ;

Fogari, E. ;

Maffioli, P. .

DIABETIC MEDICINE, 2013, 30 (07) :846-854

[5] Pioglitazone Compared to Glibenclamide on Lipid Profile and Inflammation Markers in Type 2 Diabetic Patients During an Oral Fat Load [J].

Derosa, G. ;

Cicero, A. F. G. ;

Fogari, E. ;

D'Angelo, A. ;

Bianchi, L. ;

Maffioli, P. .

HORMONE AND METABOLIC RESEARCH, 2011, 43 (07) :505-512

[6] Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience [J].

Derosa, Giuseppe ;

Maffioli, Pamela .

DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (04) :350-364

[7]

Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524

[8] Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial [J].

Goeke, Burkhard ;

Gallwitz, Baptist ;

Eriksson, Johan G. ;

Hellqvist, Asa ;

Gause-Nilsson, Ingrid .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (04) :307-316

[9] Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial [J].

Goke, B. ;

Gallwitz, B. ;

Eriksson, J. ;

Hellqvist, A. ;

Gause-Nilsson, I. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (12) :1619-1631

[10] Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration [J].

Heller, S. R. ;

Choudhary, P. ;

Davies, C. ;

Emery, C. ;

Campbell, M. J. ;

Freeman, J. ;

Amiel, S. A. ;

Malik, R. ;

Frier, B. M. ;

Allen, K. V. ;

Zammitt, N. N. ;

Macleod, K. ;

Lonnen, K. F. ;

Kerr, D. ;

Richardson, T. ;

Hunter, S. ;

Mclaughlin, D. .

DIABETOLOGIA, 2007, 50 (06) :1140-1147

← 1 2 3 →